When you want a quick, easy way to get vitamins, minerals, and amino acids directly into your bloodstream, this treatment is the way to go
Lets briefly look at the history
Hypoglycaemia risk When used as monotherapy, GLP-1 receptor agonists carry minimal hypoglycaemia risk due to their glucose-dependent mechanism
Metab Clin Exp (1996) 45:13
MicroRNA 146a is believed to interact with intracellular mediators such as interleukin 1 receptor-associated kinase 1 and mammal-affiliated tumor necrosis factor receptor-associated factor 6, both of which are involved in cytokine-related signal transduction
DSIP is not FDA-approved for any indication, is not approved in the EU, UK, or other major regulated markets, and is sold as a research chemical only